Publication Name	World Journal of Gastroenterology
Manuscript ID	56823
Country	Mexico

Received	2020-05-15 16:09
Peer-Review Started	2020-05-15 16:10
To Make the First Decision
Return for Revision	2020-05-21 20:56
Revised	2020-05-24 05:18
Second Decision	2020-09-21 10:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-09-22 05:41
Articles in Press	2020-09-22 05:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-10-18 08:55
Publish the Manuscript Online	2020-10-21 15:38

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro and Ricardo U Macías-Rodríguez
Funding Agency and Grant Number
Corresponding Author	Ricardo U Macías-Rodríguez, MD, MSc, PhD, Assistant Professor, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Mexico City 14080, Mexico. ricardomacro@yahoo.com.mx
Key Words	Non-alcoholic fatty liver disease; Liver fibrosis; Clinical assessment; Diagnosis; Treatment; Test accuracy
Core Tip	The most important liver-related factor associated with adverse clinical outcomes and mortality in patients with non-alcoholic fatty liver disease (NAFLD) is the presence and progression of fibrosis; its progression depends upon genetic, clinical, and biochemical risk factors, that must be assessed in order to identify patients at risk. To be able to accurately identify fibrosis we must take into account the diagnostic ability of each method and its possible variations according to the local prevalence and the selected cutoffs. This review summarizes the available data on assessment and management of NAFLD with a comprehensive analysis of the current diagnostic methods.
Publish Date	2020-10-21 15:38
Citation	Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(39): 5919-5943
URL	https://www.wjgnet.com/1007-9327/full/v26/i39/5919.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i39.5919

Full Article (PDF)	WJG-26-5919.pdf
Full Article (Word)	WJG-26-5919.docx
Manuscript File	56823-Review.docx
Answering Reviewers	56823-Answering reviewers.pdf
Audio Core Tip	56823-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	56823-Conflict-of-interest statement.pdf
Copyright License Agreement	56823-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	56823-Language certificate.pdf
Peer-review Report	56823-Peer-review(s).pdf
Scientific Misconduct Check	56823-Bing-Yan JP-1.png
Scientific Misconduct Check	56823-Scientific misconduct check.pdf
Scientific Editor Work List	56823-Scientific editor work list.pdf